Evidence map›Paper›PMID 42842080›Full record

ArticleInfectious diseases and therapy2026

Invasive Pneumococcal Disease in Children: A Retrospective Three-Center Study in Zhejiang Province, China (2010-2024).

Yan-Yan Zhu, Jin-Si Zhou, Jin-Hong Yang, Zhao-Jun Lu, Chao Fang, Ming-Ming Zhou, Kai-Hu Yao, Xiao-Yu Li, An-Li Sun, Julie Catusse and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Infectious diseases and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yan-Yan Zhu *Department of Pediatrics, Hangzhou Children's Hospital, Hangzhou, 310014, China.
Jin-Si Zhou *Department of Infectious Diseases, Children's Hospital Zhejiang University School of Medicine, National Clinical Research Center for Children and Adolescents' Health and Disease, Hangzhou, 310052, China.
Jin-Hong Yang *Department of Clinical Laboratory, The Second Affilated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, 325003, China.
Zhao-Jun Lu *Department of Immunization Program, Hangzhou Center for Disease Control and Prevention, Hangzhou Health Supervision Institution, Hangzhou, 310021, China.
Chao FangDepartment of Clinical Laboratory, Children's Hospital Zhejiang University School of Medicine, National Clinical Research Center for Children and Adolescents' Health, Hangzhou, 310052, Zhejiang, China.
Ming-Ming ZhouDepartment of Clinical Laboratory, Children's Hospital Zhejiang University School of Medicine, National Clinical Research Center for Children and Adolescents' Health, Hangzhou, 310052, Zhejiang, China.
Kai-Hu YaoKey Laboratory of Major Diseases in Children, Ministry of Education, National Clinical Research Center for Respiratory Diseases, National Key Discipline of Pediatrics, Laboratory of Infection and Microbiology, Beijing Pediatric Research Institute, National Center for Children's Health, Beijing Children's Hospital, Capital Medical University, Beijing, 100045, China.
Xiao-Yu LiDepartment of Clinical Laboratory, Hangzhou Children's Hospital, Hangzhou, 310014, China.
An-Li SunMedical Affairs, Pfizer Investment Co Ltd, Shanghai, China.
Julie CatusseMedical Evidence Development, Pfizer, Collegeville, PA, USA.
Eileen M DunneMedical Evidence Development, Pfizer, Collegeville, PA, USA.
Chun-Zhen HuaDepartment of Infectious Diseases, Children's Hospital Zhejiang University School of Medicine, National Clinical Research Center for Children and Adolescents' Health and Disease, Hangzhou, 310052, China. huachunzhen@zju.edu.cn.ORCID http://orcid.org/0000-0003-2829-5878

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionInvasive pneumococcal diseases (IPD) are among the leading causes of global child mortality. Pneumococcal conjugate vaccines provide direct protection against IPD caused by serotypes included in the vaccine.

objectiveTo investigate the clinical characteristics, serotypes, and antibiotic resistance of Streptococcus pneumoniae (SP) causing IPD in children in China.

methodsClinical data of IPD in children from three hospitals in Zhejiang Province, China, between January 2010 and September 2024 were retrospectively analyzed. Serotyping of SP was performed using the Quellung reaction, and antimicrobial susceptibility testing was conducted via the E-test method.

resultA total of 295 patients with IPD were identified, with ages ranging from 17 days to 13 years. Among them, 241 (81.7%) were children under 5 years old. The prevalent diagnoses included bacteremic pneumonia (33.2%), bacteremia without focus (27.1%), and meningitis (23.4%). Multiple organ damage or failure occurred in 73 patients (24.7%), pleural effusion/pyopneumothorax in 32 patients (10.8%), and septic shock in 22 patients (7.5%). There were 130 patients (44.1%) with underlying diseases, and leukemia was the most prevalent (41 patients). Sixteen patients (5.4%) died, including seven patients of purulent meningitis. Among 198 serotyped isolates, the ‌overall PCV13 serotype coverage rate‌ was 84.3%. The five most common serotypes were 19F (28.8%), 14 (13.6%), 6B (10.6%), 19A (9.6%), and 23F (9.1%). Forty-one (20.7%) isolates were resistant to penicillin, and 13.6% resistant to ceftriaxone. Serotypes 19F, 6B, and 19A exhibited significantly higher multidrug resistance rates than other serotypes (P < 0.001).

conclusionIPD is most prevalent in children under 5 years of age and children with underlying medical conditions, with bacteremic pneumonia, bacteremia without focus, and meningitis as the main clinical manifestations. PCV13 serotypes remain the most common serotypes causing IPD in this region.

Indexed as

Antibiotic resistanceInvasive pneumococcal diseaseSerotypeStreptococcus pneumoniae

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.